Form 4: Agilon Health Director Karen McLoughlin Reports Stock Transactions

Director Karen McLoughlin reports acquisition and disposal of Agilon Health (AGL) common stock and restricted stock units.

Summary

• Karen McLoughlin, a director of Agilon Health, Inc. (AGL), filed a Form 4 on May 31, 2024, reporting changes in beneficial ownership.
• On May 29, 2024, McLoughlin acquired 32,119 shares of common stock and disposed of 48,166 shares.
• The acquisition was through restricted stock units that vest in full on May 29, 2025, subject to continued service as a director.
• Following the reported transactions, McLoughlin beneficially owns 48,166 shares, including restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.

Positives

• The acquisition of restricted stock units demonstrates the director's continued commitment to the company's long-term success.

Future Outlook

The restricted stock units vest on May 29, 2025, contingent on continued service as a director.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates